Life Sciences Connect has been saved
Perspectives
Life Sciences Connect
Our podcast series on the Life Sciences and Healthcare Industries
Life Sciences Connect explores the big issues, emerging trends and cutting-edge innovations shaping the life sciences and healthcare industries. Tune in to hear the latest insight from our Centre for Health Solutions team, Deloitte leaders and key players across Pharma, Biotech, MedTech and Healthcare.
 |
Episode #28: The Future of Health in Europe Join Karen in episode 28 where you can hear our guests discuss the newly released report entitled The Future of Health in Europe. The panel dives into some of the most pressing challenges facing European healthcare and how the future must focus on collectively transforming the existing health system to prevention and well-being. Listen now |
|
Episode #27: Time to Change Join Karen on episode 27 where you can hear the authors of the Time to Change report discuss the current state of the UK healthcare workforce in terms of pay, diversity, work-life balance, and training. Listen now |
|
Episode #26: Consumer Health Join Karen on Episode 26 to hear our panel of experts discuss their views on the challenges and trends within consumer health. Hear why this is an exciting time for both consumers and companies looking to enter into or strengthen their presence in this space. Listen now |
|
Episode #25: Fireside chat with Sara Siegel Tune into the latest episode of the Life Sciences Connect podcast, where you will find Sara Siegel’s fireside chat about all things Global Healthcare. Episode 25 welcomes the new Global Head of Health and previous guest, Sara Siegel who discusses with Karen the various challenges impacting global healthcare systems today, their hopes and ambitions for the future. Listen now |
|
Episode #24: The Future of Diagnostic Imaging Karen and the team explore the findings from the Future of Diagnostic Series. The podcast explores some of the themes highlighted in our two reports on the future of diagnostics and specifically how the adoption of innovation and new models of service delivery are transforming diagnostic imaging. Listen now |
|
Episode #23: Measuring the return from pharmaceutical innovation report 2022 Karen and the team explore the findings from the annual Seize the digital momentum 2022 report. The flagship Deloitte report has provided insights into the state of biopharma R&D since 2010, with the data set expanding over the years to cover the top 20 pharma companies by R&D spend. Listen now |
|
Episode #22: State of the State report 2022/23 In episode twenty-two, we explore the challenges facing UK government and public services. Tune in as our experts discuss the issues currently facing health and social care, from unsustainable levels of funding to longstanding pressures on the workforce. Join Karen Taylor, Ed Roddis and Emma Horrell as they dissect the findings from the latest State of the State report to bring you a view of the state from the people who use and the people who run it: State of the State. Listen now |
|
Episode #21: Embedding environmental sustainability into pharma’s DNA In episode twenty-one, we explore the challenges facing pharma as they look to achieve ambitious environmental sustainability targets. The panel also evaluate ways of making progress through easy wins across the value chain, culture changes and new investment. Listen to Karen Taylor and James Gregson dive into the research found in the latest report on: Embedding environmental sustainability into pharma’s DNA. Listen now |
|
Episode #20: The Future of Diagnostics: Technology driven personalised and preventative healthcare in Europe In episode twenty, we highlight the fundamental role diagnostics plays across the entire healthcare industry, from reducing healthcare backlogs and cost saving, to improving patient outcomes. This podcast reviews our latest report: The future of diagnostics: Technology-driven personalised and preventative care in Europe. It explores the evolving role of diagnostics in shaping new clinical pathways, and the challenges that diagnostics companies face when attempting to bring their products to market. To learn more, click here LINK Listen now |
|
Episode #19: Advancing health equity to build a healthier more inclusive world Episode 19 of the Life Sciences Connect podcast sheds light on the important topic of Health equity and dives into discussions around what this really means, what businesses can do to improve this, how diversity groups are affected and much more. To learn more about health equity and other important issues facing public health in the UK, explore out Future of Public Health Series Listen now |
|
Episode #18: Hospital Activation Listen to episode eighteen of the Life Sciences Connect podcast where we talk to specialists about Hospital Activation, how we are breaking from the traditional approach and what the future holds. Listen now |
|
Episode #17: Evaluating the role of employers in reducing the public health gap: Improving the health and productivity of employees Listen to episode seventeen of the Life Sciences Connect podcast here where we continue with the Future of Public Health series and dive further into the report- Evaluating the role of employers in reducing the public health gap: Improving the health and productivity of employees. Listen now |
|
Episode #16: Negating the public health gap with Dr Karen Kirkham and Sara Siegel In episode sixteen of the Life Sciences Connect podcast, we delve into the details of the fourth report in our Future of Public Health series. Negating the gap - Preventing ill health and promoting healthy behaviours, explores the complexities of public health prevention and the challenges associated with of improving prevention and reducing health inequalities. Listen now |
|
Episode #15: Nurturing growth: Measuring the return from pharmaceutical innovation 2021 In episode fifteen of the Life Sciences Connect podcast, we dive into the conversation around our annual R&D Measuring the return from pharmaceutical innovation series report.This report analyses the projected return on investment that biopharma companies can expect to earn from their late-stage pipelines. Listen now |
|
Episode #13: Narrowing the gap: A fairer and more sustainable future for public health In our thirteenth episode of the Life Sciences Connect podcast series, we discuss the findings from The Future of Public Health Series, covered in the overview report: Narrowing the gap: A fairer and more sustainable future for public health. This first instalment of the series summarises the key takeaways from our research of the challenges pre-pandemic, the impact of COVID-19 and the implications for the future for public health systems in the UK. Listen now |
|
Episode #12: Trust in the Pharma Industry In our twelfth episode of the Life Sciences Connect podcast series, we discuss the public perception of trust in the pharma industry. We discuss the results from the research report Overcoming biopharma’s trust deficit: Why people mistrust the biopharma industry as well as discussing how COVID-19 has affected these perceptions and how the industry might improve diversity of clinical trials by improving trust. Listen now |
|
Episode #11: How can AI play a critical role in the Biopharma commercial model? Our eleventh episode of the Life Sciences Connect series explores the critical role AI plays in Biopharma launch and commercial activities. Listen now |
|
Episode #10: Seeds of change for pharma R&D returns Our tenth episode of Life Sciences Connect series explores our latest insights on pharma R&D productivity including the impact and learnings from the pandemic. Listen now |
|
Episode #9: What is driving MedTech’s transformation? Our ninth episode of Life Sciences Connect series explores the key trends for the MedTech industry including the rise in consumer organisations entering the space, the evolution from product to service, the changing regulatory landscape, and the acceleration of MedTech in healthcare because of COVID-19. Listen now |
|
Episode #8: James Gregson on trends transforming life sciences and healthcare In our eighth episode of Life Sciences Connect, we talk to Deloitte’s new Life Sciences and Healthcare leader James Gregson on what he hopes to accomplish in his new role, tips for managing work and family life along with his views on the trends transforming the industry. Listen now |
|
Episode #7: The future unmasked - Predicting the future of healthcare and life sciences in 2025 In the seventh episode of Life Sciences Connect, we discuss what the future holds for Life Sciences and Healthcare in 2025. Listen now |
|
Episode #6: Real World Evidence Our sixth podcast looks at the impact Real World Evidence has on biopharma companies, how best to implement knowledge management systems to maximise Real World Data (RWD), the importance of change management and the role skills and talent has in maximising value from RWD. Listen now |
|
Episode #5: Digital transformation in healthcare Our fifth podcast looks at the key issue of digital transformation of the healthcare systems across Europe, and the impact COVID-19 has had on accelerating progress. We discuss the findings of our report, Shaping the future of European healthcare, and get insights from those already providing digital healthcare services. Listen now |
|
Episode #4: Scaling Biotech companies in challenging times The Biotech sector is a key player in driving biopharma innovation and developing ground-breaking treatments for patients. Supporting the growth of this sector is vital to ensure that R&D efforts continue, both now and in the future. However, like most industries, this sector faces a complex set of challenges. In the fourth episode of Life Sciences Connect, we explore these challenges and the opportunities facing the Biotech Industry. Listen now |
|
Episode #3: Transforming Drug Supply Chains The COVID-19 pandemic has brought unprecedented challenges, highlighting the limitations of traditional linear supply chains and acting as a catalyst for the acceleration of digital transformation. In the third episode of Life Sciences Connect, we explore digital transformation of biopharma supply chains and adoption of artificial intelligence. Listen now |
|
Episode #2: The Future of Health In the second episode of Life Sciences Connect, we explore how the COVID-19 pandemic has accelerated the move towards the Future of Health, where technology and data enable health care that is more personalised, predictive, preventative and participatory. Listen now |
|
Episode #1: Artificial Intelligence in Clinical Trials For our first episode, we explore the use of Artificial Intelligence in clinical trials and how regulators are embracing new technologies. The current COVID-19 pandemic has caused widespread disruption to ongoing clinical trials. In response, regulatory bodies have issued patient safety-focused guidance advising sponsors to employ a risk-based approach to implementing COVID-19 contingency plans. Listen now |
Key contacts
Recommendations
The role of employers in reducing the UK’s public health gap
This report focuses on the role of employers in improving the physical and mental health of their employees through measures to address workforce wellbeing.
